New Rules Says Medicare Advantage Can't Cover These Treatments More Seniors Rely On

Source The Motley Fool

Key Points

  • Centers for Medicare and Medicaid Services is establishing new rules for Medicare Advantage Plans.

  • These rules forbid Medicare Advantage from covering a treatment method retirees are increasingly relying on.

  • The treatments can't be covered because of federal laws.

  • The $23,760 Social Security bonus most retirees completely overlook ›

Since 2018, Medicare Advantage Plans have had flexibility in what they cover, as the Bipartisan Budget Act of 2018 allowed plans to expand coverage to include Special Supplemental Benefits for the Chronically Ill. Supplementary benefits can cover things not directly related to health for people with chronic illnesses, if the services make them healthier or improve their function.

Unfortunately, a new CMS rule that's going into effect in 2026 is prohibiting some common services that could accomplish this goal, despite Medicare Advantage plans trying to cover them -- including one increasingly popular treatment.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Patient being treated by doctor.

Image source: Getty Images.

Medicare Advantage plans asked about covering this popular item

The new CMS rule addresses requests on the part of Medicare Advantage organizations to cover a service senior patients are demanding in increasing numbers: cannabis.

According to the text accompanying the new rule, "CMS has received inquiries from MA organizations about whether they are permitted to offer cannabis-based products as a supplemental benefit. In response to these inquiries, CMS has stated that medical marijuana or derivatives, such as cannabis oil, cannot be covered by MA organizations, as they are illegal substances under Federal law."

Interest in cannabis products has been growing, with an NYU study published revealing 7% of older adults were current cannabis users in 2023, compared to 4.8% in 2021. With more retirees turning to medical cannabis to address health issues, it's not surprising Medicare Advantage Plans need clarity on coverage.

CMS says cannabis can't be included in coverage

CMS has a clear answer now. With the 2026 rule change, CMS listed cannabis as a product that cannot be covered, even as a supplemental benefit.

"Medical marijuana or derivatives, such as cannabis oil, cannot be covered by MA organizations, as they are illegal substances under Federal law," the rule says.

If retirees want these products, they'll need to pay for them by making wise investment choices to generate income to cover the cost.

The $23,760 Social Security bonus most retirees completely overlook

If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets" could help ensure a boost in your retirement income.

One easy trick could pay you as much as $23,760 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. Join Stock Advisor to learn more about these strategies.

View the "Social Security secrets" »

The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Markets in 2026: Will gold, Bitcoin, and the U.S. dollar make history again? — These are how leading institutions thinkAfter a turbulent 2025, what lies ahead for commodities, forex, and cryptocurrency markets in 2026?
Author  Insights
Dec 25, 2025
After a turbulent 2025, what lies ahead for commodities, forex, and cryptocurrency markets in 2026?
placeholder
Gold selling pressure persists as traders lock in profits ahead of US NFP reportGold (XAU/USD) remains under some selling pressure for the second straight day and slides back closer to the overnight swing low during the Asian session on Thursday. The downtick lacks any fundamental catalyst and is likely to remain limited amid a supportive fundamental backdrop.
Author  FXStreet
Jan 08, Thu
Gold (XAU/USD) remains under some selling pressure for the second straight day and slides back closer to the overnight swing low during the Asian session on Thursday. The downtick lacks any fundamental catalyst and is likely to remain limited amid a supportive fundamental backdrop.
placeholder
Silver Price Forecasts: XAG/USD extends its reversal below $76.00Silver (XAG/USD) is trading lower in an otherwise calm market session on Thursday.
Author  FXStreet
Jan 08, Thu
Silver (XAG/USD) is trading lower in an otherwise calm market session on Thursday.
placeholder
Top 3 Price Prediction: Bitcoin, Ethereum, Ripple — BTC, ETH and XRP defend key support as rebound scenario stays in playBTC holds above $90,000, ETH hovers near $3,128 at the 50-day EMA, and XRP steadies above $2.07 as traders weigh rebound targets and key downside levels.
Author  Mitrade
Jan 09, Fri
BTC holds above $90,000, ETH hovers near $3,128 at the 50-day EMA, and XRP steadies above $2.07 as traders weigh rebound targets and key downside levels.
placeholder
Solana Future: From high-speed experiment to corporate treasury playbook for the next SOL cycleSolana’s Proof of History architecture is colliding with rising institutional treasury adoption and governance scrutiny, with SOL’s next cycle hinging on validator distribution, stability, and regulated capital access.
Author  Mitrade
7 hours ago
Solana’s Proof of History architecture is colliding with rising institutional treasury adoption and governance scrutiny, with SOL’s next cycle hinging on validator distribution, stability, and regulated capital access.
goTop
quote